Life SciencesRSS

  • May 11, 2007

    AIG Unit Sues Tyco Over Bond Buyback Offer

    A unit of American International Group Inc. filed suit against a Tyco International Ltd. subsidiary on Wednesday over an allegedly unfair offer Tyco has made to buy back $5.6 billion in Tyco bonds in preparation for its liquidation.

  • May 11, 2007

    Wyeth's Sales Tactics Not Anti-Competitive: Court

    A group of pharmaceutical wholesalers has lost an appeal brought against Wyeth-Ayerst Laboratories over claims the drug maker hiked up the price of its hormone medication while keeping its competitor out of the lucrative market.

  • May 11, 2007

    Court Keeps Aciphex Free Of Generic Competition

    A federal court ruled Friday that generic drug companies Teva Pharmaceutical Industries Ltd. and Dr. Reddy’s Laboratories Ltd. infringed Eisai Co. Ltd.’s patent on the ulcer medicine Aciphex.

  • May 11, 2007

    Plavix Charges Settled, But More May Be Coming

    Now that Bristol-Myers Squibb Co. has tentatively settled criminal antitrust charges with the U.S. Department of Justice, it will wait to see whether the Federal Trade Commission or states take civil action against it over a failed Plavix patent agreement.

  • May 11, 2007

    Genendo Loses Drug Importation Appeal

    The Food and Drug Administration had its power to regulate imported drugs clarified Thursday when the Seventh Circuit Court of Appeals upheld its 2003 seizure and condemnation of drugs, imported by Genendo Pharmaceuticals, that were improperly packaged and labeled.

  • May 11, 2007

    Edwards Unit Sues Rival Over Catheter Device

    A subsidiary of artificial heart valve maker Edwards Lifesciences Corp. has reached across the Atlantic to stick an Irvine, Calif.-based rival with an infringement suit over transcatheter technology.

  • May 11, 2007

    J&J Keeps Cheap Risperdal Off Shelves

    In a win for Johnson & Johnson, a U.S. appeals court has upheld a ban on the sale of a cheap version of the pharmaceutical giant’s antipsychotic drug Risperdal for the life of its key patent.

  • May 10, 2007

    Drug Bill To Change ANDA Petition Process

    A bipartisan amendment added to a bill renewing drug user fees that passed the U.S. Senate Wednesday would alter the citizen petition process for Abbreviated New Drug Applications, making it harder for brand-name drug makers to use "frivolous" petitions as a way to delay generic drugs, advocates say.

  • May 10, 2007

    U.S. Regulators Crack Down On Medicare Fraud

    U.S. regulators have recently joined forces to crack down on Medicare fraud across the country, an effort that has already netted 42 arrests of individuals allegedly connected to health care fraud schemes, the U.S. Attorney’s Office for the Southern District of Florida said Thursday.

  • May 10, 2007

    Allergan Litigates Over Eye Drop Patent

    Allergan Inc. disclosed Wednesday that it has sued generic pharmaceutical company Exela PharmSci Inc. for allegedly infringing its patent for an eye drop medication used to treat glaucoma.

  • May 11, 2007

    Group Says “Enough” In Pfizer Unit Ch. 11 Case

    With proceedings at a virtual standstill, a group of attorneys representing asbestos victims has asked the Manhattan bankruptcy court to intervene in the case of a defunct Pfizer unit and appoint a Chapter 11 Trustee.

  • May 10, 2007

    Appeals Court Calls LeapFrog's Toy Patent "Obvious"

    Upholding a ruling that a patent over a children’s educational toy was obvious and invalid, the Federal Circuit on Wednesday pronounced the end of a lawsuit between rival toymakers LeapFrog Enterprises Inc. and Fisher-Price Inc. that had dragged on for years.

  • May 10, 2007

    Boston Scientific Faces German Patent Suit

    A lawsuit lodged in Mannheim, Germany has alleged that some of Boston Scientific Corp.’s balloon catheter products infringe a German patent asserted by SciCo Tec GmbH.

  • May 10, 2007

    Purdue, Employees To Pay $700M In OxyContin Case

    The company that makes the narcotic pain killer Oxycontin and three former executives pled guilty Thursday to charges of misbranding the drug and agreed to fork over more than $700 million in payments to the government.

  • May 10, 2007

    Digene Loses Belated Bid For Ban On Rival HPV Tests

    A judge has ruled that genetic test maker Digene Corp. has suffered no irreparable harm by a rival’s sales of its patented products, denying the company’s request for a ban.

  • May 9, 2007

    Biovail Chair Fails To Reach Deal With Regulator

    Settlement talks have broken off between Biovail Corp. Chair Eugene Melnyk and the Ontario Securities Commission in its case accusing him of failing to report trades of the company’s stock placed in several trusts.

  • May 9, 2007

    Exxon Seeks Injunction Against Web Domain Buyer

    ExxonMobil Corp. claims that it is the latest victim of a habitual Internet domain name trademark infringer, which allegedly is profiting from the oil giant’s XOM trademark and confusing its employees by running a Web site with a domain name similar to the company’s pension plan site.

  • May 9, 2007

    Cardinal Health Settles Suit For $600M

    Cardinal Health Inc. will pay $600 million to settle a massive class action lawsuit that alleged the company had misled investors by overstating earnings.

  • May 9, 2007

    China's Ex-FDA Head To Go On Trial For Corruption

    The former head of China’s State Food and Drug Administration will go on trial Tuesday of next week for allegedly taking bribes to approve untested medicines and loosen quality checks in the country.

  • May 9, 2007

    Clinton Unveils Pact To Slash AIDS Drug Prices

    While developing countries continue to break AIDS drug patents, former President Bill Clinton has negotiated a new deal with two pharmaceutical giants in an attempt to provide poor nations with cheaper versions of drugs needed to combat the deadly disease.